GlassScriptPhysician profile
Hillary Howe Tassin
NPI 1376778035
$1,038.58
in general payments reported to CMS, 2019-2025
16 companies · $34.24 in 2025
The $34.24 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $148 · 2022: $169 · 2023: $556 · 2024: $131 · 2025: $34.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $722.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $721.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $142.87 | 2021 | |
| Edwards Lifesciences Corporation | $136.88 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Cvrx, INC. | $131.38 | 2024 | Barostim Neo System |
| Medtronic, INC. | $125.00 | 2023 | Micra |
| Boston Scientific Corporation | $97.12 | 2023 | Watchman Flx |
| Impulse Dynamics (USA) INC. | $84.99 | 2022 | |
| Kestra Medical Technology Services, INC. | $80.87 | 2023 | Assure Wcd |
| Alnylam Pharmaceuticals INC. | $45.58 | 2022 | |
| Biosense Webster, INC. | $41.75 | 2023 | Carto 3 |
| Philips North America LLC | $39.76 | 2023 | |
| Cleerly, INC. | $34.24 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Janssen Pharmaceuticals, INC | $20.50 | 2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.53 | 2022 | |
| Pfizer INC. | $14.38 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $13.89 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $9.84 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hillary Tassin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.